tiprankstipranks
Humacyte director buys $667.5K in common stock
PremiumThe FlyHumacyte director buys $667.5K in common stock
1M ago
Humacyte First Quarter 2024 Financial Results and Business Update
PremiumPress Releases
Humacyte First Quarter 2024 Financial Results and Business Update
1M ago
Humacyte reports Q1 EPS (29c), consensus (22c)
PremiumThe Fly
Humacyte reports Q1 EPS (29c), consensus (22c)
1M ago
Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024
PremiumPress ReleasesHumacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024
3M ago
Options Volatility and Implied Earnings Moves Today, March 22, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 22, 2024
3M ago
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
PremiumPress Releases
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
3M ago
Humacyte Announces Public Offering and Expected Proceeds
PremiumCompany AnnouncementsHumacyte Announces Public Offering and Expected Proceeds
4M ago
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference
PremiumPress Releases
Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference
4M ago
Humacyte 13.4M share Spot Secondary priced at $3.00
PremiumThe Fly
Humacyte 13.4M share Spot Secondary priced at $3.00
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100